Literature DB >> 6244587

Enhancement of free radical reduction by elevated concentrations of ascorbic acid in avian dystrophic muscle.

R C Perkins, A H Beth, L S Wilkerson, W Serafin, L R Dalton, C R Park, J H Park.   

Abstract

It has been postulated that the degenerative process in dystrophic muscle results from increased concentrations of free radicals, peroxides, or lipid hydroperoxides. Therefore, the reduction of the free radical tanol (2,2,6,6-tetramethyl-4-piperidinol-1-oxyl) by extracts of muscles of dystrophic and normal chickens was studied. Pectoral (white) and thigh (red) muscles were used. For initial rate measurements, the various muscle extracts were added to an equal volume of 0.2 mM tanol. Reaction mixtures were introduced into the EPR cavity in a standard aqueous flat cell. Rates were measured by continuously monitoring the decrease in signal amplitude of the center (MI = 0) solution tanol EPR resonance line (in-phase first harmonic absorption signal). With extracts from dystrophic white muscle, the reduction rate was 75% faster than normal, whereas in dystrophic red muscle extracts the rate was normal. This agreed with previous observations that white muscle is more severely affected than red in dystrophic chickens. The primary reductant was identified as reduced ascorbic acid, and the rate of reduction of tanol correlated directly with the concentrations of ascorbic acid in the various muscle extracts as shown by chemical analysis. The results suggest an involvement of the intracellular redox status in the pathogenesis of avian muscular dystrophy.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6244587      PMCID: PMC348366          DOI: 10.1073/pnas.77.2.790

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  12 in total

1.  ADP-ACTIVATED LIPID PEROXIDATION COUPLED TO THE TPNH OXIDASE SYSTEM OF MICROSOMES.

Authors:  P HOCHSTEIN; L ERNSTER
Journal:  Biochem Biophys Res Commun       Date:  1963-08-14       Impact factor: 3.575

2.  A rapid, simple method for the determination of reduced, dehydro-, and total ascorbic acid in biological material.

Authors:  R R SCHAFFERT; G R KINGSLEY
Journal:  J Biol Chem       Date:  1955-01       Impact factor: 5.157

3.  Glutathione peroxidase, glutathione reductase, and thiobarbituric acid-reactive products in muscles of chickens and mice with genetic muscular dystrophy.

Authors:  S T Omaye; A L Tappel
Journal:  Life Sci       Date:  1974-07-01       Impact factor: 5.037

4.  Spin-probe analysis of membrane perturbations produced by chemical and physical agents.

Authors:  M L Seligman; H B Demopoulos
Journal:  Ann N Y Acad Sci       Date:  1973-12-31       Impact factor: 5.691

5.  Lipid peroxidation damage to cell components.

Authors:  A L Tappel
Journal:  Fed Proc       Date:  1973-08

6.  Inside-outside transitions of phospholipids in vesicle membranes.

Authors:  R D Kornberg; H M McConnell
Journal:  Biochemistry       Date:  1971-03-30       Impact factor: 3.162

7.  Fiber types and preclinical changes in chicken muscular dystrophy.

Authors:  S A Shafiq; V Askanas; A T Milhorat
Journal:  Arch Neurol       Date:  1971-12

8.  Mechanism of action of penicillamine in the treatment of avian muscular dystrophy.

Authors:  J H Park; E J Hill; T H Chou; V LeQuire; R Roelofs; C R Park
Journal:  Ann N Y Acad Sci       Date:  1979       Impact factor: 5.691

9.  Beneficial effects of penicillamine treatment on hereditary avian muscular dystrophy.

Authors:  T Chou; E J Hill; E Bartle; K Woolley; V LeQuire; W Olson; R Roelofs; J H Park
Journal:  J Clin Invest       Date:  1975-10       Impact factor: 14.808

10.  Enzymological studies on hereditary avian muscular dystrophy.

Authors:  R Patnode; E Bartle; E J Hill; V LeQuire; J H Park
Journal:  J Biol Chem       Date:  1976-07-25       Impact factor: 5.157

View more
  1 in total

Review 1.  Active oxygen in neuromuscular disorders.

Authors:  A Davison; G Tibbits; Z G Shi; J Moon
Journal:  Mol Cell Biochem       Date:  1988-12       Impact factor: 3.396

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.